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Antigen-specific, CD8+, cytolytic T lymphocytes (CTLs) could potentially provide resistance
to several infectious and malignant diseases. However, the cellular requirements for the
generation of specific CTLs in human lymphocyte cultures are not well defined, and
repetitive stimulation with antigen is often required. We find that strong CD8+ CTL
responses to influenza virus can be generated from freshly isolated blood T cells, as long as
dendritic cells are used as antigen presenting cells (APCs). Small numbers of dendritic cells
(APC:T cell ratio of 1:50-1:100) induce these CTL responses from most donors in 7 d of
culture, but monocytes are weak or inactive. Whereas both dendritic cells and monocytes
are infected with influenza virus, the former serve as effective APCs for the induction of
CD8+ T cells while the latter act as targets for the CTLs that are induced. The strong CD8+
response to influenza virus-infected dendritic cells is accompanied by extensive
proliferation of the CD8+ T cells, but the response can develop in the apparent absence of
CD4+ helpers or exogenous lymphokines. CD4+ influenza virus-specific CTLs can also be
induced by dendritic cells, but the cultures initially must be depleted of CD8+ cells. These
findings should make it possible to use dendritic cells to generate human, antigen-specific,
CD8+ CTLs to other targets. The results illustrate the principle that efficient T cell-mediated
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Abstract
Antigen-specific, CD8+, cytolytic T lymphocytes (CTLs)
could potentially provide resistance to several infectious and
malignant diseases. However, the cellular requirements for
the generation of specific CTLs in human lymphocyte cul-
tures are not well defined, and repetitive stimulation with
antigen is often required. We find that strong CD8+ CTL
responses to influenza virus can be generated from freshly
isolated blood T cells, as long as dendritic cells are used as
antigen presenting cells (APCs). Small numbers of dendritic
cells (APC:T cell ratio of 1:50-1:100) induce these CTL re-
sponses from most donors in 7 d of culture, but monocytes
are weak or inactive. Whereas both dendritic cells and mono-
cytes are infected with influenza virus, the former serve as
effective APCs for the induction of CD8+ T cells while the
latter act as targets for the CTLs that are induced. The strong
CD8+ response to influenza virus-infected dendritic cells is
accompanied by extensive proliferation of the CD8+ T cells,
but the response can develop in the apparent absence of
CD4+ helpers or exogenous lymphokines. CD4+ influenza
virus-specific CTLs can also be induced by dendritic cells,
but the cultures initially must be depleted of CD8+ cells.
These findings should make it possible to use dendritic cells
to generate human, antigen-specific, CD8+ CTLs to other
targets. The results illustrate the principle that efficient T
cell-mediated responses develop in two stages: an afferent
limb in which dendritic cells are specialized APCs and an
efferent limb in which the primed T cells carry out an im-
mune response to many types of presenting cells. (J. Clin.
Invest. 1994. 94:797-807.) Key words: influenza virus * den-
dritic cells * CD8+T cells * cytotoxic T lymphocytes * vaccines
Introduction
The potential role of CD8+, cytolytic T lymphocytes' (CTLs)
in resistance to infectious and malignant diseases has been reem-
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1. Abbreviations used in this paper: APC, antigen presenting cells; CTL,
cytolytic T lymphocytes; ER+, T cell enriched; ER-, T cell depleted;
HA, hemagglutinin; HRP, horseradish peroxidase; LCMV, lymphocytic
choriomeningitis virus; MLR, mixed leukocyte reaction; NK, natural
killer cells; NP, nucleoprotein; PE, phycoerythrin.
phasized by recent developments. Antigen-specific CTLs are
recognized as a possible defense mechanism in infection with
HIV-1 (1-3), cytomegalovirus (4), and in malaria (5). Antigens
that are recognized by melanoma-specific CTLs have also been
identified by Van der Bruggen et al. (6) and Brichard et al. (7).
These studies document the specificity of CTLs that recognize
clinically important targets. Less is understood about the initial
generation of these CTLs, however.
As in most T cell responses, the precursors for active CTLs
are quiescent lymphocytes that must be induced to expand clon-
ally and develop effector functions. For CTL activation to occur,
not only must antigens be presented as peptide fragments on
MHCproducts, but the antigen-MHC complexes must also be
introduced on cells with the requisite accessory functions that
lead to T cell growth and cytolytic activity. There is evidence,
primarily from the studies of killer cells to transplantation anti-
gens, that an effective way to induce human CTLs is to present
antigens on dendritic cells (8). Dendritic cells are specialized
accessory cells for the initiation of many T cell-dependent
immune responses (for review see reference 9).
Here we have used dendritic cells to stimulate virus-specific
CTLs from human blood. The model we chose to study was
influenza. Improved mechanisms for prophylaxis and therapy
are needed in influenza, because control of the respiratory infec-
tion is not readily achieved through current approaches to vacci-
nation. For example, presently available vaccines are not de-
signed to induce killer cells but instead boost antibody responses
to viral antigens that undergo antigenic drift and shift (10). It
is known that dendritic cells are a component of the alveolar
septae and airway epithelium of the lung (11, 12) and that the
appearance of influenza virus-specific CTLs is associated with
a more rapid clearance of virus from nasal washings (13). Influ-
enza virus is also the agent used to dissect the different pathways
for antigen presentation and analyze the specificity of CTLs.
Townsend and associates (14, 15) realized that viral proteins
were processed in the cytoplasm and presented as peptides in
association with class I MHCproducts of the infected cell.
Morrison et al. (16) used influenza virus to distinguish the two
pathways for antigen presentation to CTLs. One emanates from
acidic endocytic vesicles and leads to presentation on MHC
class II to CD4+ CTLs; the other emanates from a nonacidic
biosynthetic compartment for presentation on MHCclass I to
CD8+ CTLs. The CTLs that have been the subject of work in
humans are usually generated from unseparated blood mononu-
clear cells and/or repeated stimulation of responding lympho-
cytes with exogenous IL-2 and viral antigens (4, 5, 13, 14, 17-
22). For example, Carreno et al. (17) used repeatedly stimulated
human blood cells in their elegant mapping studies of influenza
peptides that are presented to CTLs. In this study, we identify
an effective accessory cell system to generate human influenza-
specific killer cells.
Weshow that influenza A virus establishes a nontoxic infec-
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tion of human dendritic cells and that these infected dendritic
cells induce the development of strong virus-specific CTLs
within 7 d. Three features of the response will be stressed: both
strong CD8+ T cell proliferation as well as CTL activity are
evident, the killer cells once generated recognize and kill in-
fected MHCclass I-matched monocytes, and no exogenous
cytokines or CD4+ helpers are required.
Methods
Culture medium
RPMI 1640 (Gibco Laboratories, Grand Island, NY) supplemented with
100 yg/ml gentamicin, 5%human serum, and 10 mMHepes buffer.
Blood mononuclear cells
In most experiments, buffy coats served as sources of PBMCs and
were obtained from the New York Blood Center (New York, NY).
Blood donors were also healthy volunteers who were HLA typed and
selected for MHCclass I mismatch. PBMCswere separated into T cell-
enriched (ER+) and T cell-depleted fractions (ER-) as previously
described (23).
T cells. ER+ cells were first depleted of monocytes by panning on
dishes coated with human gamma globulin (24). MHCclass 11+ and
natural killer (NK) cells (CD16+ and CD1lb+) were depleted by coat-
ing with mAbs 9.3C9 (ATCC;HB 180), and 3G8 (gift of Dr. Jay Unke-
less) and OKMI (ATCC;CRL 8026), respectively, followed by panning
on petri dishes coated with goat anti-mouse IgG (8). The resulting T
cell population contained < 2-3% of contaminating MHCclass 11+
and NKcells, as monitored by cytofluorography. In some experiments,
T cells were enriched for CD4+ or CD8+ cells by incubation with
Leu 2 or Leu 3 mAbs, respectively, followed by panning as above.
CD4+ and CD8+ cells were > 95% pure when evaluated by staining
with PE-conjugated Leu 2 or Leu 3 (Becton Dickinson & Co., Mountain
View, CA), both before and after the culture period that was used to
generate influenza responses.
APCpopulations. Monocytes were obtained from ER- cells by
adhering them onto plastic dishes for 60-90 min and dislodged by
pipetting. Nonadherent cells were subsequently used for purification of
B cells and dendritic cells, as described previously (24, 25). Residual
monocytes were first removed by panning on gammaglobulin-coated
plates (24). The ER-, FcR- cells proved to be adequately enriched in
the dendritic cells that are needed as APCs for strong CTL responses.
However, to further enrich the dendritic cells, and the potency of the
APCs, ER-, FcR- cells were layered onto 14% metrizamide gradients
(25). After sedimentation, dendritic cells localize to the low density
interface, whereas B cells and NKcells are enriched in the high density
interface. Dendritic cell purity was 50-70% with contaminants being
B cells, NK cells, and a few T cells.
Virus preparation
Influenza virus strain PR8 (A/Puerto Rico/8/34) was kindly provided
by Dr. Peter Palese (Mount Sinai School of Medicine, New York) in
the form of infectious allantoic fluid. Virus was grown up and purified
as previously described (26). Virus stocks were replenished from seed
virus by Spafas Inc. (Storrs, CT) and stored in liquid nitrogen (virus
stock: 20,000 HAU/ml). Virus titers were determined using a hemagglu-
tination assay, as previously described (26).
Infection of cells
APCs and target cells were washed out of medium containing serum
and resuspended in RPMI at 0.5-1 x 107 cells/ml. Virus was added at
a final concentration of 1,000 HAUPR8/ml and incubated for 60 min
at 37°C. This dose is saturating for the induction of influenza-specific
CTLs. To determine whether influenza infection proceeded through an
acidic compartment in APCs, the cells were incubated in 10 mMNH4Cl
for 30 min before adding virus and throughout the subsequent infection.
In some cases, the NH4Cl was added throughout the culture period,
which was generally 24 h.
Induction of influenza-specific CTL
1 X 106 purified T cells were cultured in 24-well plates (Costar, Cam-
bridge, MA) with graded doses of influenza virus-infected or uninfected
APCs, in a total volume of 1.1 ml. After 7 d of culture, the cells were
harvested and distributed in varying numbers to 96-well microtiter plates
[100 Al per well]. CTL activity was measured using a 5"Cr-release assay
with infected or uninfected syngeneic monocytes as targets. 1 X 104
targets in a volume of 50 jld were added to each well to generate E:T
ratios ranging from 1:1 to 100:1.
SJCr release assay
Monocytes were obtained from ER- cells by adhering them onto plastic
dishes for 60-90 min and dislodged by pipetting. 1 x 107 monocytes
were cultured in 10 ml volumes in 60-ml Teflon beakers (Savillex Corp.,
Minnetonka, MN) until use as targets in the CTL assay (27). For 5"Cr
labeling and infection, cells were collected on ice, washed free of serum,
and brought up to 1 x 107/ml in RPMI. 400 yCi Na51CrO4 (1 mCi/ml
sterile stock; New England Nuclear, Boston, MA) was added per 1
x 10' monocytes. They were simultaneously infected with 1,000 HAU
PR8/ml for 1 h at 370C. The targets were washed four times and resus-
pended at 2 x 105/ml, after which 50 sl was aliquoted to each well
containing effector T cells. Spontaneous and total release samples were
prepared by adding the targets to wells containing RPMI alone or a
final concentration of 0.33% SDS, respectively. The plates were centri-
fuged for 2 min at 15 g and incubated for 5 h at 370C. At the termination
of the assay, the supernatant was collected with absorption cartridges
using a harvesting press (Skatron Instruments Inc., Sterling, VA) and
counted in a gammacounter. Percent specific 5"Cr release was calculated
from the following formula: 100 x [(Release by CTL - spontaneous
release)/(Total release - spontaneous release)]. Spontaneous release was
15-25% of the total release.
FACSanalysis of cell populations and cell sorting
After culture with uninfected or virus-infected APCs, T cells were phe-
notyped by staining with Simultest CD4-FITC/CD8-PE or Simultest
control (Becton Dickinson) and analyzed on a FACScan (Becton-Dick-
inson). In some experiments, T cells were separated into CD4+ and
CD8+ subsets by sorting on a FACStar Plus (Becton Dickinson).
1 x 107 cells were stained with 20 Al of Simultest CD4-FITC/CD8-
PE (Becton Dickinson) for 45 min at 4°C, washed three times, and
sorted. CD4+ cells were collected as FITC+ cells whereas CD8+ cells
were PE+. Contamination of CD4+ cells with CD8+ cells or vice versa
was < 1%. Sorted populations were stained again after a period of 7 d
and did not demonstrate any change in their CD4/CD8 phenotype. The
antibodies did not appear to block function because purified populations
could respond to influenza virus-infected APCs (see Results).
Detection of influenza virus infection by
immiunohistochemistry
Cytospins of various cell populations were prepared using a Cytospin
2 centrifuge (Shandon, Inc., Pittsburgh, PA). Slides were fixed in acetone
for 5 min at room temperature and then incubated in hybridoma superua-
tant for 45 min. The mAbs to influenza virus proteins were kindly
provided by Dr. J. Yewdell, National Institutes of Health, and included
anti-NP (H16-,10-4R5; ATCC HB65) and anti-HA (H28E23 and
H17L2). The cytospins were washed several times with PD/1% BSA,
and incubated with 1:200 dilution of biotinylated goat anti-mouse Ig
(Boehringer Mannheim Biochemicals, Indianapolis, IN), for 45 min,
followed by a horseradish peroxidase (HRP)-biotin-avidin complex
(ABC kit; Vector Laboratories, Inc., Burlingame, CA) for 30 min. Non-
bound HRPwas then washed off, and the HRP reaction product was
developed with H202 and diaminobenzidine tetrahydrochloride (Poly-
sciences, Warrington, PA).
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Lymphocyte proliferation assay
After infection with influenza virus, APCs were added in graded doses
to 1 x 105 T cells in 96-well flat-bottomed plates (Costar). Uninfected
APCs served as controls. Proliferation was determined on days 5-6
with the addition of 4 MCi/ml of [3H]TdR for 12-16 h to triplicate
microwells (mean cpm).
Results
Influenza virus uptake and infection in human dendritic cells.
There is considerable evidence, primarily in mouse cell cultures,
that dendritic cells effectively present viral antigens to T cells
(26, 28-30). Murine dendritic cells can be infected by influenza
virus and elicit potent CTL responses (26, 29). The responses
are dependent upon the synthesis of endogenous viral proteins
(26). Wewished to determine the extent to which human den-
dritic cells could be infected with influenza virus. Dendritic
cells were isolated from buffy coat preparations as previously
described and pulsed with live influenza virus for 1 h in serum-
free medium. After multiple washes, immunohistochemistry
was used to detect two viral proteins, NP and HA, within the
cell, from 1 to 16 h after infection (Fig. 1). In addition, dendritic
cells were compared with macrophages isolated from the same
donor.
Dendritic cells failed to stain with isotype-matched antibody
OKT8 (Fig. 1 A) but stained intensely with mAbto MHCclass
II (Fig. 1 B). At 16 h after infection, NP staining was primarily
localized to the nucleus of dendritic cells, although there was
clearly a cytoplasmic distribution in addition (Fig. 1 C). A
diffuse distribution of HA, consistent with endogenous viral
protein synthesis, was evident (Fig. 1, D and E). Greater than
90% of the dendritic cells were infected by these criteria, with
a viability of > 90%. The NP and HA patterns of staining at
16 h after infection indicate extensive synthesis of viral proteins
in the dendritic cells. Uninfected dendritic cells did not stain
with any mAbs for viral-specific proteins (data not shown).
After just 1 h of infection, dendritic cells expressed HA
primarily in a granular pattern, suggesting that the virus is first
contained within endocytic vacuoles (Fig. 1 F). Evidence of
viral protein synthesis was also apparent in that there was dif-
fuse cytoplasmic staining of a few cells at this early time point
(Fig. 1 F, black arrows). Pretreatment of dendritic cells with
NH4Cl before, during, and after a virus pulse blocked infection,
i.e., few cells (< 2%) stained with either anti-HA or anti-NP
mAbs (data not shown). These findings confirm that influenza
requires an acidic compartment to deliver its genome to the
cytoplasm and engage in viral-specific protein synthesis. Macro-
phages were also highly susceptible to infection with influenza.
The degree of infection was generally > 70% (Fig. 1, G and
H). After overnight incubation following infection, many cells
died and appeared to be phagocytosed by viable macrophages
(Fig. 1 G, black arrow). In contrast, dendritic cells showed no
change in viability for up to 2 d after infection.
Lymphocytes also were examined by immunolabeling for
their ability to be infected by influenza virus, but none appeared
to be as infected as dendritic cells. B cells and T cells were not
susceptible to infection as assessed by staining with anti-HA
and NP mAbs. T cell blasts generated with superantigens had
a low level of infection ( 10-30% of the -total T cell preparation),
whereas EBV-transformed cells had weak staining in 10-30%
of the cells.
Relative efficacy of different influenza virus-pulsed APCs
to induce T cell proliferative responses. Enriched populations
of different APCs were pulsed with live influenza virus, and
their ability to stimulate T cell proliferation was assessed. Virus-
pulsed dendritic cells were 30-50-fold more effective than mac-
rophages and > 200-fold more effective than B cells (Fig. 2).
Influenza-specific responses were detectable even when one
dendritic cell was used per 300 T cells. At these stimulator/
responder ratios, influenza virus-pulsed macrophages and B
cells were unable to induce T cells to proliferate (Fig. 2). We
noted that in cultures containing significant numbers of infected
macrophages, e.g., at T cell/APC ratios of 10:1 or bulk cultures
of PBMCs, there was striking toxicity and death of most cells,
including T cells.
Dendritic cells are potent stimulators for the induction of
influenza-specific killer cell responses. Wecompared dendritic
cells and macrophages for their capacity to generate human
virus-specific CTL responses. The responding T cells were
extensively depleted of APCs and added at a constant dose of
1 X 106 (see Methods). APCs were then added in graded doses.
In dozens of experiments, the T cells never generated lytic
activity unless APCs were added, and the APCs themselves did
not form lytic cells. Dendritic cells, if infected with influenza
virus, generated significant CTL responses even when used at
a 100:1 T cell/dendritic cell ratio (Fig. 3 A). Significant killing
was seen in the primary effector cell populations even at E/T
ratios of 10:1 (Fig. 3 B) or less (data not shown). In contrast,
macrophages were far less stimulatory, in the order of 100-
fold or less, possibly due to the significant macrophage death
observed after infection with virus. Since B cells are poor stimu-
lators of the proliferative response to influenza and do not get
infected with the virus (see above), it is unlikely that contami-
nating B cells in our dendritic cell population account for the
CTL that are generated. OKM1, an mAbdirected towards the
CD1lb antigen, known to remove NK cell precursors (8), was
used to deplete these cells from the starting T cell population.
Thus, the effector cell population used in these assays is com-
posed of T cells. Experiments to be described below showed
the killers to be CD8+CD4-. Most donors, > 90%, could be
stimulated to form CTLs with virus-infected dendritic cells,
indicating that the majority of our donor pool has been exposed
to influenza. Because CTL activity was measured on influenza
A/PR8-infected targets, a strain first identified in 1934, and the
prevalent strains are A/Texas/36/91 and A/Beijing/32/92, the
CTLs generated appear to be cross-reactive, confirming other
studies of human influenza-specific CTLs (18).
Knowing that B cells do not contribute to CTL development,
we next determined whether a partially purified preparation
of dendritic cells (i.e., omitting the metrizamide column for
enrichment) was adequate for generating CTL responses to in-
fluenza. ER-, FcR- preparations are depleted of most T cells
and monocytes and consist of 5% dendritic cells, the re-
maining cells being primarily B cells. At T/APC ratios of 3:1
or 10:1, significant CTL responses were apparent (Fig. 4). This
corresponds to a T/dendritic cell ratio of 60:1 to 180:1. ER-,
FcR- cells were used as stimulators for all subsequent experi-
ments, in T/APC ratios varying from 3:1 to 5:1. These partially
enriched populations (a) suffice to provide the cultures with
dendritic cells in the 0.5-1.5% range, (b) lack inhibitory mono-
cytes, and (c) are straightforward to prepare.
To ascertain when lytic activity was optimal, we measured
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Figure 1. Following infection with influ-
enza virus, dendritic cells express HAand
NP proteins. (A-E) Dendritic cells were
pulsed with virus for 60 min, washed ex-
tensively, and then cultured for 16 h. (F)
Dendritic cells were cultured for 1 h after
the virus pulse. (G and H) Purified mono-
cytes were infected with influenza virus
as above and cultured for 16 h. At the
end of the culture period, cells were col-
lected and cytospins were prepared and
stained with the following panel of mAbs:
(A) Control mAb, anti-CD8 (OKT8).
Black arrows depict contaminating
CD8+ T cells in the APCpopulation. A
white arrow illustrates a negatively
stained dendritic cell. (B) Anti-MHC
class II (9.3C9). The three-headed arrow
identifies typical dendritic cells. (C)
Anti-NP (HB65). The black arrow points
to the intense nuclear location of NP in
a dendritic cell. The white arrow illus-
trates a negatively stained contaminating
lymphocyte. (D) Anti-HA (H17L2). The
arrow points to a typical dendritic cell.
(E-G) Anti-HA (H28E23). In E, the
arrows identify typical dendritic cells,
with hairy processes as expected for a
plasma membrane envelope protein. In
F, white arrows point to the granular ap-
pearance of HApresumably in endosomal
granules; black arrows point to the diffuse
location of HA in a few rapidly infected
dendritic cells. In G, dying infected
monocytes are phagocytosed by nonin-
fected cells (black arrow). (H) Anti-NP
(HB65). NP is detected in several dying
and live monocytes.
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Figure 2. Influenza virus-infected dendritic cells stimulate T cell prolif-
erative responses. Bulk T cells were tested in a standard proliferation
assay for responsiveness to influenza virus-infected and noninfected
dendritic cells, macrophages, and B cells at various T/APC ratios. Cul-
tures were pulsed on day 5 for 9 h with 4 btCi/ml of [3H]TdR. Results
are means of triplicates.
CTL development over the course of 9 d. Lytic activity peaked
at day 7 (Fig. 5), consistent with other studies (18) with little
variation from donor to donor. At this time, microscopic exami-
nation routinely showed the development of large cell clusters
and released T cell blasts, as is characteristic of dendritic cell-
mediated T cell responses in vitro (9). Occasionally, assays
were done on day 8 if the clusters seemed slow to develop, and
blast release was delayed.
CD8+ T cells are the principal CTLs induced with infected
dendritic cells. To establish the types of influenza-specific ef-
fector cells in our system, we stimulated bulk T cells with



















3x1 04 105 3x10510 3x1
Stimulator Dose
Figure 4. Partially enriched preparations of dendritic cells suffice as
stimulators of influenza-specific CTL responses. 1 x 106 purified T cells
were cultured with graded doses of uninfected (open symbols) or in-
fected ER-, FcR- cells comprising - 5% dendritic cells (closed sym-
bols). Lytic activity was measured on syngeneic targets on day 7 of
culture at E/T ratios of 60:1 and 20:1. Lysis of uninfected target cells
was < 5% at all stimulator doses and E/T ratios used.
infected dendritic cells for 7 d and then separated the popula-
tions into CD4+ and CD8+ subsets. The cultures were stained
with CD4-FITC and CD8-PE mAbs (see Methods) and sorted
on a FACStar into > 98% pure CD4+ and CD8+ populations.
Unseparated as well as sorted cells were then evaluated for lytic
activity. Table I shows the data from three individual experi-
ments. Influenza-specific lytic activity was seen in two popula-
tions: bulk T cells and purified CD8+ T cells. CD4+ T cells
failed to demonstrate any lytic activity. In general the CD8+
cells were enriched for lytic activity compared with the bulk T
cells (experiments 1 and 2). FACS analyses of the stimulated
cultures contained many enlarged T blasts and most of the
enlarged cells were CD8+; few CD4+ cells appeared to enlarge
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Figure 3. Dendritic cells are potent stimulators for the induction of
influenza-specific CTL responses. (A) 1 x 106 purified T cells from
buffy coat donors were stimulated with graded doses of uninfected (open
symbols) or influenza virus-infected (closed symbols) dendritic cells or
monocytes. After 7 d, CTL activity was measured using infected synge-
neic monocytes as targets at E/T ratio of 40:1. Lysis of uninfected target
cells was < 5%at all doses of stimulators used (not shown). (B) Purified
T cells were cultured with uninfected or infected dendritic cells or
monocytes at T/APC ratios of 30:1 for 7 d. Lytic activity was measured
on syngeneic monocyte targets at various Ef/T ratios, as shown. Lysis
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Figure 5. Kinetics of CTL development. Purified T cells obtained from
a buffy coat donor were stimulated with partially enriched populations
of uninfected (open symbols) or influenza virus-infected (closed sym-
bols) dendritic cells at T/APC ratios of 3:1. Lytic activity was measured
at day 5, 7, or 9 on infected syngeneic monocyte targets. Lysis of
uninfected monocyte targets was < 5% at all time points assayed.
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Table I. Influenza Virus-specific CTL in Bulk Cultures Are
CD8+ CD4-
Percent specific lysis of macrophage targets
Experiment 1 Experiment 2 Experiment 3
Responding Infection M4i MO MO M4i MO M4b
T cells of APCs (-) Flu (-) Flu (-) Flu
Bulk (-) 0 0 0 0 2 4
Flu 0 25 0 42 9 51
CD4+ (-) 0 0 0 0 4 8
Flu 0 0 0 0 4 9
CD8+ (-)* 3 7 0 0 3 9
Flu 2 37 0 57 16 54
E/T ratio 40:1 40:1 50:1
Purified T cells were stimulated with partially enriched populations of
uninfected or influenza virus-infected dendritic cells at T/APC ratios
of 3:1. After 7 d of culture, the T cells were stained with CD4-FITC
and CD8-PE mAbs and sorted on a FACStar Plus. The CD4+ and
CD8+ populations were > 98% pure. Lytic activity of each population
was measured on infected syngeneic monocyte targets. Uninfected den-
dritic cells failed to stimulate influenza specific CTL. Three individual
experiments are shown. * In experiment 1, the E/T ratio in the CD8+
T cell group was 30:1.
To ascertain whether dendritic cell-induced CD8+, influ-
enza-specific CTLs were class I restricted, we evaluated re-
sponses generated in two individuals who differed at class I
loci but shared class II specificities (DRw52, DQw1). Donor A
demonstrated significant lytic activity against syngeneic in-
fected macrophage targets (Fig. 7) but lesser activity against
class I mismatched targets (donor B macrophage targets). Like-
wise, donor B effector cells lysed syngeneic but not allogeneic
(donor A) targets. The small degree of cross-reactivity seen in
the case of A effectors versus B targets may be due to unspeci-
fied but shared class I antigens or, possibly, the development
of CD4+-mediated CTL activity, which has been described in
cloned human populations (31, 32). However, the latter is less
likely given that no CD4+ CTLs are generated in our system
(see below).
Purified CD4+ and CD8+ T cells respond to influenza vi-
rus-infected dendritic cells. The observation that few CD4+ T
cells seemed to be undergoing proliferation was surprising,
since their role as helper cells for influenza virus-specific CTL
responses is evident in mouse cultures (26). Also human CD4+
T cell clones with lytic activity have been described (31, 32).
To determine whether CD4+ T cells could respond to influenza
virus-infected APCs, we used cell sorting to purify CD4+ and
CD8+ T cells before T cell stimulation. Bulk, sorted CD4+,
or CD8+ T cells, and a combination of both sorted populations
were tested in a standard proliferation assay for responsiveness
to influenza virus-infected ER-, FcR- cells. All four groups
were able to mount proliferative responses to these APCs (Fig.
8). The most prominent response was demonstrated by the
CD8+T cells (note the lower background) compared with either
bulk or CD4+ T cells. The extent of these responses were
generally similar at several time points tested.
When CTL responses from these populations were mea-
sured, two striking observations were made. First, sorted CD8+
T cells developed CTL activity without a requirement for CD4+
T cells (Fig. 9). These observations are reminiscent of human
alloreactive responses, in which CD4+ helper cells are not re-
quired for the generation of CD8+ CTL if dendritic cells are
the APCs (8). Second, CD4+ T cells also developed lytic activ-
ity, but only in the absence of CD8+ T cells. Weconfirmed
that the sorted populations were > 98%pure at the termination
of the 7-d induction period. Thus, contamination of the CD8+
T cells with CD4+ T cells, or vice versa, does not account for
these results. It is more likely that CD4+ T cells only exhibit
the capacity to become CTLs when few or no CD8+ T cells
are present.
Discussion
Experimental conditions for the generation of human CD8+
CTLs. To generate CD8+ CTLs against infectious agents in
cultures of human T cells, one commonly uses unseparated
populations of PBMCsand/or repeated stimulation in the pres-
ence of exogenous lymphokines such as IL-2 (4, 5, 13, 14, 17-
22). These requirements for CD8+ CTL development stand in
contrast to CD4+ T cell responses, which often are detected
within 3-5 d of culture without exogenous lymphokines. Fur-
thermore, the primary APCs that induce CTL responses in hu-
manT cell cultures have not been well characterized. Wereport
here that strong influenza virus-specific CTLs can be induced
using virus-infected dendritic cells as APCs. Partially enriched
dendritic cells, which are straightforward to isolate, suffice for
the development of CTLs. Our data extend prior reports that
human dendritic cells can induce proliferative T cell responses
to influenza virus (33).
Four features distinguish our system for generating CTLs
from the bulk culture systems that have been used previously.
First, only a few dendritic cells (0.5-1% suffice) are able to
generate highly potent CTL, as demonstrated by the fact that
killing is evident at EIT ratios of 1.5:1 (Fig. 5). Such efficacy
has not been described in CTLs generated from cultures of bulk
PBMCs (13, 14, 18, 21). Second, depletion of monocytes is
necessary to remove potential inhibitory and toxic effects on the
effector cells. In attempts to generate CTLs from unseparated
PBMCs, we often observed significant cell death that prohibited
killer cell development. This was likely secondary to cytopathic
effects of viral infection in monocytes (Fig. 1), as previously
described (34, 35). PBMCscontain about 1% dendritic cells
(36), and an Ia+ cell is known to be required for the generation
of influenza virus-specific CTL in bulk PBMCculture systems
(18). Wesuggest that these small numbers of dendritic cells are
sufficient to permit CTL development in circumstances where
few monocytes are present or become infected. Third, although
monocytes do not induce CTLs effectively, they serve as effi-
cient targets in short-term chromium-release assays (5 h). Dur-
ing this time interval, a majority of monocytes express viral
proteins as demonstrated by immunohistochemistry (data not
shown). In contrast, standard target cells, e.g., B cell lines or
PHA-treated lymphocytes, have a low level of infection (10-
30%) and are less efficient in our hands as targets. Fourth,
effector cell populations are routinely depleted of NK cells.
These cells, which are activated by dendritic cells in vitro to
lyse tumor cell targets (8), may play a role in viral clearance.
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Figure 6. CD4/CD8 phenotype in bulk T cell populations responding to influenza virus antigens. Bulk T cells were cultured with uninfected or
infected APCs for 7 d, after which they were phenotyped for CD4 or CD8 expression as described in Methods. Dot plots are of forward versus
side scatter (left), anti-CD4-FITC versus forward scatter (middle) or anti-CD8-PE versus forward scatter (right). Note that the majority of large
cells responding to infected APCs are CD8+. Control mAbs did not stain the T cells (not shown).
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Figure 7. Evidence that human influenza-specific CTL are class I re-
stricted. Donors A and B, who differ at class I but share class II antigens
[DRw52, DQwI], served as sources of T cells and APCs. T cells were
cultured with infected or uninfected syngeneic APCs for 7 d, after which
the cells were harvested for CTL activity. Lytic activity was measured
on syngeneic and allogeneic macrophage targets. Uninfected APCs
failed to elicit CTL activity (data not shown).
They are not ordinarily depleted in bulk culture systems and,
therefore, could potentially mask specific CTL measurement.
APC requirements for the generation of influenza virus-
specific CTLs. T cell-mediated immunity develops in two
stages. In the afferent phase, dendritic cells bearing antigen
initiate T-dependent responses from resting lymphocytes. Once
activated, the sensitized T lymphoblasts can interact with other
APCs in the efferent phase, to induce a number of effector
functions, e.g., B cell antibody synthesis (37), macrophage acti-
vation, and IL-1 production (38). As demonstrated here with
influenza virus, dendritic cells serve in a similar capacity to first
induce the generation of CD8+ CTLs, which then acquire the
ability to kill infected macrophage targets. These pathways for
CTL generation are potentially important for the prevention of
cell-cell spread of virus.
Several features may account for the observed differences
between dendritic cells and monocytes in the induction of influ-
enza-specific CTLs. One appears to be the manner in which
influenza virus infection is handled by these two types of APCs.
Greater than 90% of dendritic cells expressed HA, NP, (Fig. 1)
and NS-1 (not shown) within 16 h and remained fully viable
for > 24 h after infection. In sharp contrast, freshly isolated
monocytes or week-old cultured macrophages were infected to
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Figure 8. Purified CD4+ and CD8+ T cells proliferate to influenza
virus-infected dendritic cells. CD4+ and CD8+ T cells were purified
from a bulk T cell population to > 98%by staining with specific mAbs,
followed by sorting on a FACStar Plus, as described in Methods. Bulk
T cells, sorted CD4+, CD8+, and a combination of both sorted popula-
tions (CD4/CD8 cell ratio of 2:1 ) were tested in a standard proliferation
assay for responsiveness to influenza virus-infected ER-, FcR- cells.
The T/APC ratio was 5:1. Clear bars represent the responses to unin-
fected APCs whereas shaded bars represent the influenza virus-specific
responses. Cultures were pulsed on day 5 for 12 h with 4 pCi/ml of
[3H]TdR. Results are means of triplicates ±SD. Note the log scale on
the y-axis.
a lesser extent (< 70%) but died within 16 h of infection (Fig.
1). In addition to influenza virus, dendritic cells are specialized
APCs for the presentation of several other viruses to T cells,
including HSV(30), Moloney leukemia virus (28), Sendai virus
(28) in the mouse, and HIV in humans (39). It is not known
whether the efficacy of dendritic cells in part reflects better
developed pathways for the handling of viral antigens, e.g.,






nevertheless are consistent with other studies showing that den-
dritic cells present microbial antigens (M. tuberculosis [40],
Leishmania [41], and staphylococcal enterotoxins [42]) effi-
ciently to T cells.
Dendritic cells are also distinguished from APCs like mono-
cytes and B cells in the efficiency with which they deliver
signals to the TCR-CD3 complex on T cells. For example,
occupancy of only 0.1% of dendritic cell surface class II mole-
cules with superantigen is sufficient to induce T cell prolifera-
tion (23). This is due in part to the fact that dendritic cells
express and upregulate many accessory molecules that are criti-
cal during the initiation of T cell immune responses (e.g., MLR
[43] and superantigens [23]). They include B7/BB1 (CD80),
ICAM-1 (CD54), and LFA-3 (CD58), ligands for CD28,
CD1la, and CD2, respectively. Although we have yet to study
the role of these accessory molecules on dendritic cells in CTL
induction, there is evidence that interaction of CD28 with its
ligand is a critical element in the activation of cytotoxic CD8+
T cells (44). For example, murine class I restricted CTLs to
alloantigens can be generated in the absence of help from CD4+
T cells, provided a CD28-B7 interaction occurs in the induction
phase (44). Furthermore, B7-transfected tumor cells can induce
protective (CD8+ T cell-mediated) antitumor responses in vivo
when CD4+ T cells are absent (45, 46). If dendritic cells are
key accessories in CTL induction, one would predict that these
APCs should be effective in the generation of CTL responses
to other antigens (e.g., melanoma antigens, alloantigens) where
B7 is known to amplify the T cell response (43, 45, 46). The
CD28-B7/BB 1 interaction provides a critical costimulatory
mechanism for IL-2 gene expression (47-49). This would ex-
plain the CD4 helper independence of CTL induction by den-
dritic cells, i.e., their ability to present antigen together with
costimulatory molecules like B7/BB 1 that enhance the produc-
tion of IL-2.
Helper cells are not required for the generation of CD8+






Figure 9. Dendritic cells stimulate
the development of both CD4+
4.. and CD8+ influenza virus-spe-
50:1 12:1 cific CTL. Bulk T cells and sorted
purified CD4+ or CD8+ cells
were stimulated with uninfected
(open symbols) or infected (closed
symbols) ER-, FcR- cells for 7
d. The T/APC ratio was 3:1. Cyto-
lytic activity was measured on un-
infected and infected syngeneic
monocytes. CD4+ and CD8+
cells were also added together at
a 2:1 ratio before the CTL assay
(last panel on right).




















cells can be induced by dendritic cells to develop influenza
virus-specific cytolytic activity. As in bulk cultures of T cells,
CTL activity is generated with relatively few dendritic cells
(Fig. 9). Dendritic cells also directly induce human and murine
CD8+ T cells to develop cytotoxic activity in the MLR(8, 50).
In contrast to these findings, Nonacs et al. (26) found that mouse
dendritic cells were unable to induce influenza virus-specific
CTL activity in purified CD8+ T cells unless a source of CD4+
T cells or helper lymphokines was available. A key variable
here may be the number of antigen-specific IL-2 producers
in the primed CD8+ population. For example, the paucity of
precursor T cells in the mouse (1:16,600 to 1:2,400 [51]) may
be insufficient to generate enough lymphokine to amplify a CTL
response. Also, far fewer murine dendritic cells (< 20%, [26])
are capable of synthesizing viral proteins than human blood
dendritic cells (> 90%, Fig. 1).
There are now several examples of CTL development in the
apparent absence of CD4 help in vivo. For example, elimination
of CD4+ T cells in mice does not ablate resistance to ectromelia
virus (52), LCMVor vaccinia virus (53), and tumors (45, 46).
Extensive proliferation of CD8+ T cells- in response to in-
fluenza virus-infected dendritic cells. The majority of T cells
that proliferate to influenza virus antigens in bulk cultures are
CD8+. Wemade this observation in routine FACS®analyses
of stimulated cultures (Fig. 6), in which most enlarged T cells
stained with antibodies to CD8. Primary populations of human
CD8+T cells, depleted of CD4+T cells, also proliferate exten-
sively after exposure to influenza virus-infected dendritic cells.
The proliferative responses were considerably greater when
compared with bulk or CD4+ T cell responses (Fig. 8). Other
than responses to MLRantigens (8), we are not aware of other
systems where such extensive antigen-dependent CD8 blasto-
genesis takes place. In mice, after intraperitoneal infection with
LCMV, large increases in CD8+ T cells occur in the spleen as
well as the peritoneum (54).
Influenza virus-specific CD4+ CTL are also generated by
dendritic cells. Highly purified CD4+ cells can be induced by
blood dendritic cells to proliferate and develop cytolytic activity
(Figs. 8 and 9). However, it is necessary to remove the CD8+
T cells to observe both the blastogenesis and CTL responses.
The reasons for this are unclear. Weconsidered the possibility
that, in bulk cultures, CD8+ CTLs might kill the CD4+ cells.
Alternatively, there might be selective inhibition of exogenous
antigen presentation via the class H pathway, as previously
described for influenza virus-infected murine APCs (55). This
seemed unlikely for two reasons. First, CD4+ T cells can re-
spond directly to infected dendritic cells when separated from
CD8+ T cells. Second, influenza virus-infected APCs could
present PPD to M. tuberculosis-reactive CD4+ T cell clones
as well as uninfected APCs (data not shown).
Influenza-specific CD4+ CTL have been described in both
human and mouse systems (16, 31, 32). In contrast to CD8+
CTLs, CD4+ class H-restricted CTLs lysed target cells treated
with noninfectious influenza virus or purified HA preparations
and class II presentation was sensitive to lysosomotropic agents
(16). These differences provided critical early evidence that
MHCclass I- and class H-restricted CTL, depended upon
divergent pathways for presentation of antigen. The role of
CD4+ CTL in viral clearance and recovery from infection,
however, remains to be determined. ,6-2-Microglobulin defi-
cient (-/-) mice have few CD8+ T cells but can clear vaccinia
virus and nonlethal HKX31 influenza A virus and resist a low
inoculation dose of PR8 (56), but recovery from lethal doses
of the virulent strain seems to require the presence of CD8+ T
cells (57). In contrast, /8-2-microglobulin deficient (-/-) mice
infected with LCMVintracranially develop CD4+ CTL that
mediate disease, similar to their CD8+ counterparts in infected
normal strains (58).
Potential uses of CD8+ CTLs in influenza prophylaxis and
therapy. Influenza A virus infection remains a major cause of
mortality and morbidity, primarily because the control of the
respiratory illness has not been achieved through vaccination.
Current vaccines are designed to boost antibody responses to
viral antigens (HA and NA) that undergo antigenic drift and
shift (10). Consequently, the protective effects of antibodies
decline with time. Vaccines directed towards the induction of
influenza virus-specific cytotoxic T cell immune responses
might be far more effective, because CTL have been shown to
express cross-reactivity in recognition of subtypes of influenza
A (18). There is evidence in humans that CTL responses play
a role in recovery from infection. McMichael et al. (13) related
levels of CTL immunity to clearance of nasal virus by normal
donors inoculated with live virus. A clear association was ob-
served between CTL responses and clearance of virus.
An ideal vaccine would use cross-reactive antigens, induce
CD8+ CTL responses in most hosts, and have an efficient
means of delivery. Several approaches to induce CTLs with
these properties have been attempted in a number of systems.
They include delivery of class I-restricted peptides with adju-
vant (59-62), conjugated to lipid (63), complexed with im-
mune-stimulating complexes (64), or inserted into liposomes
(65, 66). The injection of DNAencoding the immunizing anti-
gen directly into skeletal muscle (67) has also been reported to
induce CTL.
Until recently, dendritic cells have not been directly considered
in strategies to design new vaccines that generate CD8+ CTLs.
Targeting antigen to dendritic cells has several advantages: one
can maximiz the efficiency of T cell activation (9) and avoid
anergy induction (68) or the use of adjuvants (69). For example,
dendritic cells pulsed with antigen in vitro and delivered in vivo
to mice have been highly effective for generating CD4+ immune
responses to protein antigens and microbes (69, 70). Mouse den-
dritic cells pulsed with class I-restricted peptides of NP(26), HIV
peptides (71), or given antigen via pH-sensitive liposomes (66)
into the cytoplasm can induce CTL responses.
A pivotal role for dendritic cells in human disease prophy-
laxis and therapy is suggested by their ability to directly induce
strong CD8+ CTL responses, as shown here for influenza virus.
It may be possible to pulse dendritic cells directly with NP
peptides or with attenuated virus, for instance, and use these
APCs in vivo to elicit CTL responses. By adapting the systems
developed in this study, dendritic cells could also be used for
generating large numbers of CD8+ CTL, for adoptive transfer
to immunosuppressed individuals who are unable to mount nor-
mal immune responses. Immunotherapy with CD8+ CTL has
been shown to amplify the immune response. Bone marrow
transplant recipients given CMV-specific CTL by adoptive
transfer do not develop disease or viremia (4). These novel
approaches for immunoprophylaxis and therapy should be appli-
cable to several situations where CD8+ CTLs are believed to
play a therapeutic role, e.g., HIV infection (1-3), malaria (5),
and malignancies such as melanoma (6, 7).
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